In vivo impact of prodrug isosorbide-5-nicotinate-2-aspirinate on lipids and prostaglandin D2: Is this a new immediate-release therapeutic option for niacin?
Mark T. Ledwidge, Fiona Ryan, David M. Kerins, Damian O’Connell, Gene Cefali, Shona Harmon, Michael Jones, John F. GilmerVolume:
221
Year:
2012
Language:
english
DOI:
10.1016/j.atherosclerosis.2012.01.016
File:
PDF, 464 KB
english, 2012